Laxmikant Kabra HUF Revised's most recent trade in Eiko Lifesciences Ltd. was a Acquisition of 34,982 Equity Shares done at an average price of Rs. 48.5 . Disclosure was reported to the exchange on May 25, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Laxmikant Kabra HUF Revised's has made SAST transactions in Eiko Lifesciences Ltd. recently where a Acquisition of 20,000 shares done . Disclosure was reported to the exchange on May 24, 2024.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eiko Lifesciences | Laxmikant Kabra HUF (Revised) | Promoter | Acquisition | 23 Aug 2024 | 20,000 | 1,416,666 (10.22%) | 0.14% | - | 23 May 2024 23 May 2024 |
SAST (29(2)) | - | Market | |
Eiko Lifesciences | Laxmikant Kabra HUF (Revised) | Promoter | Acquisition | 23 Aug 2024 | 3,334 | 1,420,000 (10.24%) | 0.02% | - | 28 May 2024 28 May 2024 |
SAST (29(2)) | - | Market | |
Eiko Lifesciences | Laxmikant Kabra (HUF) (Revised) | Promoter Group | Acquisition | 25 May 2022 | 34,982 | 77,684 (0.93%) | 0.42% | 48.5 | 1,697,727 | 24 May 2022 24 May 2022 |
Insider Trading | Equity Shares | Market Purchase |
Eiko Lifesciences | Laxmikant Kabra (HUF) (Revised) | Promoter | Acquisition | 17 May 2022 | 7,357 | 7,357 (0.08%) | 0.08% | - | 13 May 2022 13 May 2022 |
SAST (29(2)) | - | Market |